Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27360%2F25%3A10258921" target="_blank" >RIV/61989100:27360/25:10258921 - isvavai.cz</a>
Result on the web
<a href="https://link.springer.com/article/10.1007/s13205-025-04353-y" target="_blank" >https://link.springer.com/article/10.1007/s13205-025-04353-y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13205-025-04353-y" target="_blank" >10.1007/s13205-025-04353-y</a>
Alternative languages
Result language
angličtina
Original language name
Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine
Original language description
Ganoderma lucidum (Reishi), a valued medicinal fungus used in traditional medicine for over 2000 years, has sparked widespread scientific attention due to its extensive range of bioactive ingredients and therapeutic promise in modern medicine. This study presents a detailed and up-to-date examination of G. lucidum's primary bioactive components, which include polysaccharides, triterpenoids, meroterpenoids, nucleotides, proteins, alkaloids, and sesquiterpenoids. These chemical components show a wide range of pharmacological effects, including immune modulation, cancer suppression, and neuroprotection. The review also gives insight on developing and underexplored therapeutic areas, such as the mushroom's antiviral properties particularly its anti-HIV potential as well as its anti-fibrotic, neuropharmacological, and anti-aging benefits. By combining traditional therapeutic knowledge with modern biomedical innovation, G. lucidum is positioned as a viable natural resource for solving modern health issues. Continued study is required to understand the molecular processes that underpin its many effects and to assist its incorporation into evidence-based medicinal applications. It subsequently emphasizes and thoroughly examines G. lucidum's bioactive components, as well as insights into its rising role in healthcare, combining traditional knowledge with recent biological achievements.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10600 - Biological sciences
Result continuities
Project
—
Continuities
O - Projekt operacniho programu
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
3 Biotech
ISSN
2190-572X
e-ISSN
2190-5738
Volume of the periodical
15
Issue of the periodical within the volume
7
Country of publishing house
DE - GERMANY
Number of pages
21
Pages from-to
nestránkováno
UT code for WoS article
001503363400001
EID of the result in the Scopus database
—